The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Complement-dependent Cytotoxicity Testing Services Market Research Report 2025
Synopsis
Complement-dependent cytotoxicity assay (CDC) is an in vitro cell-based assay used to evaluate the cytotoxic ability of antibodies against target cells. CDC is based on the activation of the complement system and the formation of the membrane attack complex (MAC). In the CDC assay, target cells and antibodies are mixed, and then complement is added. Complement activation leads to the formation of MAC, resulting in the death of target cells. By measuring the survival rate of target cells or the release of molecules that represent cell death, the cytotoxic ability of the antibody can be evaluated. CDC is commonly used in the research and development of antibody drugs, vaccines, and immunotherapies, as well as in the evaluation of the efficacy of these treatments.
Global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Complement-dependent Cytotoxicity Testing Services market research.
Key companies engaged in the Complement-dependent Cytotoxicity Testing Services industry include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Complement-dependent Cytotoxicity Testing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Complement-dependent Cytotoxicity Testing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Complement-dependent Cytotoxicity Testing Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Complement-dependent cytotoxicity assay (CDC) is an in vitro cell-based assay used to evaluate the cytotoxic ability of antibodies against target cells. CDC is based on the activation of the complement system and the formation of the membrane attack complex (MAC). In the CDC assay, target cells and antibodies are mixed, and then complement is added. Complement activation leads to the formation of MAC, resulting in the death of target cells. By measuring the survival rate of target cells or the release of molecules that represent cell death, the cytotoxic ability of the antibody can be evaluated. CDC is commonly used in the research and development of antibody drugs, vaccines, and immunotherapies, as well as in the evaluation of the efficacy of these treatments.
Global Complement-dependent Cytotoxicity Testing Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Complement-dependent Cytotoxicity Testing Services market research.
Key companies engaged in the Complement-dependent Cytotoxicity Testing Services industry include Creative Biolabs, iQ Biosciences, Horizon Discovery, Sino Biological, Inc., GenScript ProBio, Agilent and Sartorius, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Complement-dependent Cytotoxicity Testing Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Complement-dependent Cytotoxicity Testing Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Complement-dependent Cytotoxicity Testing Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Creative Biolabs
iQ Biosciences
Horizon Discovery
Sino Biological, Inc.
GenScript ProBio
Agilent
Sartorius
Segment by Type
Common Type
High Throughput Type
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Cell Engineering
Medical Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Complement-dependent Cytotoxicity Testing Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Complement-dependent Cytotoxicity Testing Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Common Type
1.2.3 High Throughput Type
1.3 Market by Application
1.3.1 Global Complement-dependent Cytotoxicity Testing Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biopharmaceuticals
1.3.3 Medical Diagnosis
1.3.4 Cell Engineering
1.3.5 Medical Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Complement-dependent Cytotoxicity Testing Services Market Perspective (2018-2029)
2.2 Complement-dependent Cytotoxicity Testing Services Growth Trends by Region
2.2.1 Global Complement-dependent Cytotoxicity Testing Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Complement-dependent Cytotoxicity Testing Services Historic Market Size by Region (2018-2023)
2.2.3 Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Region (2024-2029)
2.3 Complement-dependent Cytotoxicity Testing Services Market Dynamics
2.3.1 Complement-dependent Cytotoxicity Testing Services Industry Trends
2.3.2 Complement-dependent Cytotoxicity Testing Services Market Drivers
2.3.3 Complement-dependent Cytotoxicity Testing Services Market Challenges
2.3.4 Complement-dependent Cytotoxicity Testing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Complement-dependent Cytotoxicity Testing Services Players by Revenue
3.1.1 Global Top Complement-dependent Cytotoxicity Testing Services Players by Revenue (2018-2023)
3.1.2 Global Complement-dependent Cytotoxicity Testing Services Revenue Market Share by Players (2018-2023)
3.2 Global Complement-dependent Cytotoxicity Testing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Complement-dependent Cytotoxicity Testing Services Revenue
3.4 Global Complement-dependent Cytotoxicity Testing Services Market Concentration Ratio
3.4.1 Global Complement-dependent Cytotoxicity Testing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Complement-dependent Cytotoxicity Testing Services Revenue in 2022
3.5 Complement-dependent Cytotoxicity Testing Services Key Players Head office and Area Served
3.6 Key Players Complement-dependent Cytotoxicity Testing Services Product Solution and Service
3.7 Date of Enter into Complement-dependent Cytotoxicity Testing Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Complement-dependent Cytotoxicity Testing Services Breakdown Data by Type
4.1 Global Complement-dependent Cytotoxicity Testing Services Historic Market Size by Type (2018-2023)
4.2 Global Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Type (2024-2029)
5 Complement-dependent Cytotoxicity Testing Services Breakdown Data by Application
5.1 Global Complement-dependent Cytotoxicity Testing Services Historic Market Size by Application (2018-2023)
5.2 Global Complement-dependent Cytotoxicity Testing Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Complement-dependent Cytotoxicity Testing Services Market Size (2018-2029)
6.2 North America Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2018-2023)
6.4 North America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Complement-dependent Cytotoxicity Testing Services Market Size (2018-2029)
7.2 Europe Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Complement-dependent Cytotoxicity Testing Services Market Size by Country (2018-2023)
7.4 Europe Complement-dependent Cytotoxicity Testing Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size (2018-2029)
8.2 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Complement-dependent Cytotoxicity Testing Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Complement-dependent Cytotoxicity Testing Services Market Size (2018-2029)
9.2 Latin America Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2018-2023)
9.4 Latin America Complement-dependent Cytotoxicity Testing Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size (2018-2029)
10.2 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Complement-dependent Cytotoxicity Testing Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Biolabs
11.1.1 Creative Biolabs Company Detail
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Complement-dependent Cytotoxicity Testing Services Introduction
11.1.4 Creative Biolabs Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.1.5 Creative Biolabs Recent Development
11.2 iQ Biosciences
11.2.1 iQ Biosciences Company Detail
11.2.2 iQ Biosciences Business Overview
11.2.3 iQ Biosciences Complement-dependent Cytotoxicity Testing Services Introduction
11.2.4 iQ Biosciences Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.2.5 iQ Biosciences Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Complement-dependent Cytotoxicity Testing Services Introduction
11.3.4 Horizon Discovery Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Sino Biological, Inc.
11.4.1 Sino Biological, Inc. Company Detail
11.4.2 Sino Biological, Inc. Business Overview
11.4.3 Sino Biological, Inc. Complement-dependent Cytotoxicity Testing Services Introduction
11.4.4 Sino Biological, Inc. Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.4.5 Sino Biological, Inc. Recent Development
11.5 GenScript ProBio
11.5.1 GenScript ProBio Company Detail
11.5.2 GenScript ProBio Business Overview
11.5.3 GenScript ProBio Complement-dependent Cytotoxicity Testing Services Introduction
11.5.4 GenScript ProBio Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.5.5 GenScript ProBio Recent Development
11.6 Agilent
11.6.1 Agilent Company Detail
11.6.2 Agilent Business Overview
11.6.3 Agilent Complement-dependent Cytotoxicity Testing Services Introduction
11.6.4 Agilent Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.6.5 Agilent Recent Development
11.7 Sartorius
11.7.1 Sartorius Company Detail
11.7.2 Sartorius Business Overview
11.7.3 Sartorius Complement-dependent Cytotoxicity Testing Services Introduction
11.7.4 Sartorius Revenue in Complement-dependent Cytotoxicity Testing Services Business (2018-2023)
11.7.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
